Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China

Journal of Dermatological Science

Volumn 53, Issue 3, 2009, Pages 212-215

  Wu, Jie ^a   Chen, Feng ^a   Zhang, Xuelong ^a   Li, Yuzhen ^a   Ma, Hongyu ^b   Zhou, Yucheng ^a   Jin, Yan ^a   Wang, Haikuan ^a   Bai, Jing ^a   Zhang, Guiyin ^a   Fu, Songbin ^a,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

^c Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

MIF; Polymorphism; Promoter; Psoriasis

Indexed keywords

MIGRATION INHIBITION FACTOR;

ADULT; ALLELE; ARTICLE; ASIAN; CHINA; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; PSORIASIS; RISK FACTORS; YOUNG ADULT;

EID: 58649086924     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.11.002     Document Type: Article

References (30)

1. Gomez R.S., Diepgen T.L., Neumann C., and Sorg C. Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin. Arch Dermatol Res 282 (1990) 374-378
2. Arias A.I., Giles B., Eiermann T.H., Sterry W., and Pandey J.P. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 14 (1997) 118-122
3. Ravindran J.S., Owen P., Lagan A., Lewis J., Korendowych E., Welsh K., et al. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43 (2004) 22-26
4. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., et al. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 30 (2002) 161-166
5. Radstake T.R., Sweep F.C., Welsing P., Franke B., Vermeulen S.H., Geurts-Moespot A., et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52 (2005) 3020-3029
6. Sanchez E., Gomez L.M., Lopez-Nevot M.A., Gonzalez-Gay M.A., Sabio J.M., Ortego-Centeno N., et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 7 (2006) 433-436
7. Fei B.Y., Lv H.X., Yang J.M., and Ye Z.Y. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 41 (2008) 44-47
8. Oliver J., Marquez A., Gomez-Garcia M., Martinez A., Mendoza J.L., Vilchez J.R., et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 56 (2007) 150-151
9. Wu S.P., Leng L., Feng Z., Liu N., Zhao H., McDonald C., et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 54 (2006) 3661-3669
10. Shimizu T., Nishihira J., Mizue Y., Nakamura H., Abe R., Watanabe H., et al. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 116 (2001) 989-990
11. Donn R.P., Shelley E., Ollier W.E., and Thomson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 44 (2001) 1782-1785
12. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46 (2002) 2402-2409
13. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3 (2002) 170-176
14. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
15. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., et al. Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol Rep 19 (2008) 223-228
16. Reich K., Mossner R., Konig I.R., Westphal G., Ziegler A., and Neumann C. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 118 (2002) 155-163
17. Kim Y.K., Pyo C.W., Choi H.B., Kim S.Y., Kim T.Y., and Kim T.G. Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. J Dermatol Sci 48 (2007) 133-139
18. Mallon E., Bunce M., Wojnarowska F., and Welsh K. HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics. J Invest Dermatol 109 (1997) 183-186
19. Burden A.D., Javed S., Bailey M., Hodgins M., Connor M., and Tillman D. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 110 (1998) 958-960
20. Donn R.P., Plant D., Jury F., Richards H.L., Worthington J., Ray D.W., et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 123 (2004) 484-487
21. Nevitt G.J., and Hutchinson P.E. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 135 (1996) 533-537
22. Yip S.Y. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 10 (1984) 965-968
23. Donn R.P., and Ray D.W. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182 (2004) 1-9
24. Vivarelli M., D'Urbano L.E., Stringini G., Ghiggeri G.M., Caridi G., Donn R., et al. Association of the macrophage migration inhibitory factor-173*C allele with childhood nephrotic syndrome. Pediatr Nephrol 23 (2008) 743-748
25. Martinez A., Orozco G., Varade J., Sanchez Lopez M., Pascual D., Balsa A., et al. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 68 (2007) 744-747
26. Plant B.J., Gallagher C.G., Bucala R., Baugh J.A., Chappell S., Morgan L., et al. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 172 (2005) 1412-1415
27. Gomez L.M., Sanchez E., Ruiz-Narvaez E.A., Lopez-Nevot M.A., Anaya J.M., and Martin J. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens 70 (2007) 28-33
28. Nohara H., Okayama N., Inoue N., Koike Y., Fujimura K., Suehiro Y., et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 39 (2004) 242-246
29. Hizawa N., Yamaguchi E., Takahashi D., Nishihira J., and Nishimura M. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 169 (2004) 1014-1018
30. Lan Q., Shen M., Garcia-Rossi D., Chanock S., Zheng T., Berndt S.I., et al. Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics 59 (2007) 839-852